Asan Medical Center
Seoul, 138-736, South Korea
NCT Number: NCT00682045
The aim of this study is to estimate the usefulness of a T cell-based assay (i.e. T-SPOT.TB assay) for diagnosis of latent tuberculosis infection (LTBI) in renal transplant recipients. For this purpose, the investigators enrolled renal transplant recipients and observed the developement of tuberculosis within 1 to 2 years after the transplantation.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Seoul, 138-736, South Korea
We evaluate the usefulness of a newly-developed T cell-based assay prior to undergoing immunosuppression in renal transplant recipients. Among all renal transplant recipients, patients with negative tuberculin skin test and no other indications for latent tuberculosis infection will be enrolled in this study. We will exam T-SPOT.TB test in these patients, and observe the developement of tuberculosis within 1 to 2 years after the transplantation. The results of T-SPOT.TB will be blinded to the investigators.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: within 2 years after transplantation
Time frame: within 2 years after transplantation
Asan Medical Center
Other
A Prospective Observational Study of Usefulness of a T Cell-based Assay for Latent Tuberculosis Infection in Renal Transplant Recipients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03016455
Renal Transplant
Amiens, France
View Trial DetailsNCT02894606
Renal Transplant
Brest, France
View Trial DetailsNCT04838288
Renal Transplant
Nashville, Tennessee, United States
View Trial DetailsNCT04572854
C3 Glomerulonephritis, C3 Glomerulopathy
Phoenix, Arizona, United States
View Trial Details